Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTENSIMIX trial of biphasic insulin aspart regimens plus metformin in type 2 diabetes
2004-002778-50Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of biphasic insulin aspart, insulin aspart, biphasic insulin aspart 70 and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Novo Nordisk. Primary endpoint: HbA1c. Started Jan 2005; status: completed.
02
Drugs
biphasic insulin aspartinsulin aspartbiphasic insulin aspart 70metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-002778-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002778-50.